22nd May 2023

Stockley’s Drug Interactions

For this update, the monoclonal antibodies chapter has been updated with 59 new drugs, and monographs have been added for tenapanor and the chimeric antigen receptor (CAR) T-cell therapies, axicabtagene ciloleucel, ciltacabtagene autoleucel, idecabtagene vicleucel, and tisagenlecleucel. In addition, the drug metabolism monograph has been reorganised and a new table of examples of possible drugs metabolised by, or affecting, UGTs has been included. In total there are 33 new monographs and 85 revised monographs in this update.

22nd May 2023

Pharmaceutical Excipients

This update contains 28 updated monographs. Pharmacopoeias have been globally updated.

Revised monographs: Crospovidone; Dibutyl phthalate; Diethyl phthalate; Dimethyl phthalate; Dimethyl sulfoxide; Dodecyl gallate; Ethanol; Ethyl lactate; Glycerin; Glyceryl dibehenate; Histidine; Hydroxypropyl cellulose; Imidurea; Lysine acetate; Poloxamer; Polydextrose; Polyethylene glycol; Polyethylene oxide; Polyoxyethylene sorbitan fatty acid esters; Povidone; Starch, pregelatinized; Triethanolamine.

Selective Revisions: Calcium sulfate; Octyl gallate; Propyl gallate; Propylene glycol; Sorbitol; Vegetable oil, hydrogenated.

Note: This update contains a name change of the Glyceryl behenate record to Glyceryl dibehenate. Additionally, the Corn starch and pregelatinized starch, coprocessed record has been removed.

22nd May 2023

Palliative Care Formulary

This update contains 1 new monograph and 6 revised monographs.

New Monograph: Myasthenia gravis at the end of life.

The following monographs have been fully revised: End-stage heart failure; End-stage idiopathic Parkinson’s disease; General principals for prescribing in palliative care; Prescribing for the elderly; Reviewing medication when a patient is close to death.

The following monographs have undergone minor revision: Antipsychotics.

22nd May 2023

ASHP Injectable Drug Information

This update contains 10 new monographs, 40 revised monographs and 1 new MedWatch alert.

New monographs: Atezolizumab; Avelumab; Cemiplimab; Dostarlimab; Durvalumab; Ipilimumab; Nivolumab; Pembrolizumab; Terlipressin Acetate; tremelimumab.

Revised monographs: Acetylcysteine; Amoxicillin Sodium; Bamlanivimab; Bupivacaine Hydrochloride; Casirivimab-Imdevimab; Ceftriaxone Sodium; Coagulation Factor Xa (Recombinant), Inactivated-zhzo; Dexmedetomidine Hydrochloride; Dimenhydrinate; Diphenhydramine Hydrochloride; Etesevimab; Fat Emulsion, Intravenous; Fentanyl Citrate; Fluorouracil; Gentamicin Sulfate; Granisetron Hydrochloride; Heparin Sodium; Hyaluronidase; Hydrocortisone Sodium Succinate; Hydromorphone Hydrochloride; Ketamine Hydrochloride; Leucovorin Calcium; Methylprednisolone Acetate; Methylprednisolone Sodium Succinate; Midazolam Hydrochloride; Morphine Sulfate; Neostigmine Methylsulfate; Octreotide Acetate; Oliceridine Fumarate; Oxacillin Sodium; Penicillin G Potassium; Pentobarbital Sodium; Phenobarbital Sodium; Potassium Chloride; Promethazine Hydrochloride; Sodium Chloride; Sodium Lactate; Sotrovimab; Valproate Sodium; Vancomycin Hydrochloride.

New MedWatch alerts on the following monograph: Potassium Phosphates.

22nd May 2023

Electronic Medicines Compendium (emc)

For May, 67 new medicines have been added, and numerous medicines have been amended.

22nd May 2023

Drug Monitoring Checker

This update contains 4 new monographs.

New monographs: Allopurinol; Febuxostat; Colchicine; Clomipramine hydrochloride.”